NASDAQ:ENZN - Nasdaq -
Photo by Yiorgos Ntrahas on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
CRANFORD, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its 20...
Under the board approved rights offering to existing shareholders, Enzon Pharmaceuticals' (OTC:ENZN) seeks to distribute one transferable subscription right for each outstanding share of common stock owned.For every 1,105 subscription rights held, a shareholder will be entitled to purchase one unit.Enzon plans to offer 40K units at a subscription price of $1,090/unit; each unit will consist of one preferred share par value $1,000, and 750 common stock shares.With no voting rights, preferred stock holders will be entitled to receive cumulative dividends at the rate per share of 3% p.a., if paid in cash, or 5% p.a., if paid in-kind.
Before 10 am on Wednesday, 52 companies set new 52-week highs. Highlights: Assicurazioni Generali (OTC: ARZGF) was the largest firm by market cap to set a new 52-week high....
Mentions: VTNL